Aquilo Capital Management - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2010
Aquilo Capital Management focuses on investing in drug development companies that leverage cutting-edge science to address urgent medical needs. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to revolutionize medical practices. Aquilo's investments typically target post-IPO equity rounds.
The firm's portfolio includes notable companies such as Pieris Pharmaceuticals, which has raised $32 million. Aquilo Capital aims to support biotechnology firms that offer both substantial risk-adjusted returns and paradigm-changing therapeutics for patients and society. Their investment philosophy centers on identifying opportunities that can bring dramatic advances to the biotechnology sector and transform medical solutions.
Aquilo Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages